SCHEMBL23383176

SCHEMBL23383176

CC1(OC(=O)c2ccccc2C(=O)OC2(C(F)(F)C(=O)O)CCCCC2)CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN1A P35498 2/20 0.43
▸ SCN2A Q99250 2/20 0.43
▸ SCN3A Q9NY46 2/20 0.43
▸ CYP19A1 P11511 1/20 0.36
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.32
▸ CCR2 P41597 1/20 0.32
▸ HSD11B1 P28845 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ P2RX7 Q99572 1/20 0.31
▸ TSHR P16473 2/20 0.30
▸ FAAH O00519 1/20 0.30
▸ TRPV1 Q8NER1 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23383172 0.87 CYP19A1 (0.37) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL23383175 0.86 ADRA1A (0.34) SCN1ASCN2ASCN3ACYP3A4CYP2D6
SCHEMBL31192379 0.83 SCN1A (0.52) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL304215 0.83 SCN1A (0.52) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL3411398 0.82 SCN1A (0.54) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL31077823 0.82 SCN1A (0.54) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL6404697 0.81 SCN1A (0.51) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL23383018 0.80 SCN1A (0.42) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL23382490 0.79 SCN1A (0.43) SCN1ASCN2ASCN3ACYP19A1CYP3A4
SCHEMBL23383017 0.79 SCN1A (0.43) SCN1ASCN2ASCN3ACYP19A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-09-19 — — US disclosed
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-05-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11762287-B2 Onium salt compound, chemically amplified resist composition and patterning process IDUA, SLC6A5, SLC6A9 SCN1A 1012/4885SCN2A 1220/4885SCN3A 1477/4885
US-20210149301-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS IDUA, SLC6A5, SLC6A9 SCN1A 1012/4885SCN2A 1220/4885SCN3A 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback